SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors - Wikidata - awgldk - TriplyDB

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors

http://www.wikidata.org/entity/Q35551005

about

Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression Nuclear DNA damage signalling to mitochondria in ageing HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.Wnt5a Signals through DVL1 to Repress Ribosomal DNA Transcription by RNA Polymerase I.The protein-interaction network with functional roles in tumorigenesis, neurodegeneration, and aging.Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium.SIRT7, H3K18ac, and ELK4 Immunohistochemical Expression in Hepatocellular Carcinoma.Fascin Induces Epithelial-Mesenchymal Transition of Cholangiocarcinoma Cells by Regulating Wnt/β-Catenin Signaling SIRT7-dependent deacetylation of the U3-55k protein controls pre-rRNA processing.SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis.Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis.SIRT7-dependent deacetylation of CDK9 activates RNA polymerase II transcription The seven faces of SIRT7.SIRT7 Is Activated by DNA and Deacetylates Histone H3 in the Chromatin Context.Sirt7 promotes adipogenesis in the mouse by inhibiting autocatalytic activation of Sirt1.Sirtuin 7: a new marker of aggressiveness in prostate cancer.Long noncoding RNA and mRNA profiling in MDA-MB-231 cells following RNAi-mediated knockdown of SIRT7.CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/β-catenin signaling pathway.Sirtuins at the crossroads of stemness, aging, and cancer.Sirtuins in the Cardiovascular System: Potential Targets in Pediatric Cardiology.Diabetes induces fibrotic changes in the lung through the activation of TGF-β signaling pathways

P2860

Q26744502-23A219EC-08A6-41F8-B805-483C656BA56D Q26769965-F664999C-62BF-4A3C-B34E-EB5ABE9DF950 Q28396642-148EF985-495B-4878-B8D7-8589C0661674 Q33733042-E3BDEAF3-B4CF-470D-AFE5-4D04F3896740 Q33894922-3BE0D5D5-B927-4248-940D-A41AFBA07220 Q36097475-4830AE1F-0EC0-415A-A661-4617750401A3 Q36152451-8F72C7F3-4B15-422E-B8FF-5DB9B7D08F38 Q36738761-33CED579-3F4C-4D17-8C3E-A7C126B80A80 Q37297802-875AFBAF-E110-4ECA-81AB-3498C78CC20B Q37302969-6E48F30C-FCAC-4575-98D1-87EF01AD5888 Q38463603-9658BE61-114F-4AE5-A361-6D8289DB4692 Q38615281-9A127957-05CF-40C8-9D91-A73B4ECE3431 Q38698832-E487064C-6DAF-48D1-A2BB-A62968475425 Q38706788-B56C4669-0AEA-4CE2-88DE-6532A71434F9 Q39076651-FC9931CB-9BF1-4202-BD8A-FD055229B499 Q40803150-F552424C-D241-4D34-ABA1-9C15762A9C7D Q42263658-7AA5C87A-4BD9-4E10-A170-CFC6CB076FAC Q46309794-22F1578F-3C87-430B-84FF-05F64CBD193D Q46800418-8937E95B-D8E0-4CFE-BFE9-2AA2D9CDD56D Q47114935-51ED45E4-8722-4C7E-9882-59D6EF562441 Q47237639-06F6955E-9768-48BD-BE60-C82D384DB652 Q55341014-C9DAB3B3-1986-4AD8-BB7A-B9ABF882BA7C Q58793875-DE78B95E-8D4C-4783-8AEE-AD74E6C3E2FC

P2860

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors

http://www.wikidata.org/entity/Q35551005

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors

@ast

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors

@en

type

label

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors

@ast

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors

@en

prefLabel

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors

@ast

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors

@en

P1433

Q35551005-E47F7FCB-05D7-4C52-B9E4-EB69441BEF19

P1476

Q35551005-34E8C22A-774F-4C3A-917F-70441248E8AB

P2093

Q35551005-0143C07D-811B-456C-AC1C-44DD77EE9E3D

Q35551005-28E7AB18-5328-423D-BE52-70F2C9903C2E

Q35551005-2B91020F-9923-4F3B-B89D-82BBA08FF1EB

Q35551005-2E4E83A7-2163-46A2-A635-1BBFAEC511B6

Q35551005-7F14C4C5-7F44-43F0-8422-43E795BF9C24

Q35551005-97B0A181-5298-4D1B-8F25-37A6845767F1

Q35551005-A8C1CA00-F135-4D98-934F-284C05B727B6

Q35551005-E761935F-B8C3-4104-9200-E3CCDDC9B0EB

P2860

Q35551005-032C0B9E-4F13-4F7E-B096-4838385989E7

Q35551005-08E34A9D-DEB9-4AA8-A6FA-0C8A3542F61A

Q35551005-0C1F5C9D-01B3-4331-8F12-DC5DAFBE0F96

Q35551005-1B911D2A-BA7C-4545-A311-C0A9CD8AC31F

Q35551005-27B8665D-39D4-4B28-9195-77DB9BEA4A70

Q35551005-28317366-9B28-4798-BC8B-62B2D4D83DEB

Q35551005-3139DEB6-9BB1-4FFF-8DD4-AD4F237E3E0B

Q35551005-3696A75D-65D2-42C2-8699-26A02001179D

Q35551005-379572E6-3641-4C1E-B2F1-39EAA08C828B

Q35551005-3B8C721C-B383-4609-9674-2ADC2BBA0626

P2888

Q35551005-B3F8C92C-05E5-413B-ABE9-A9A1849CE54E

P304

Q35551005-1352ABAA-35D7-4F9B-9FC1-809A7D5D9DF7

P31

Q35551005-3CFB0B23-2626-4133-A926-23E53077AF45

P356

Q35551005-3C6A585B-3FCA-4125-95E2-AEB2B22A4972

P407

Q35551005-1C9B45CD-1D87-433C-B8AC-4267C5264F47

P478

Q35551005-714F4827-3EB3-4370-A068-E7E55923E5C3

P50

Q35551005-2F57E917-ED3A-421D-8C7C-C3A7A9FC4808

P577

Q35551005-71B6D2A2-985B-42D9-ABEC-21599DE168F6

P5875

Q35551005-ED41CA89-7927-43B5-BA89-25106BA7AEB6

P698

Q35551005-DCE03460-53ED-429F-912F-F39D60532264

P932

Q35551005-6BABBB8B-B6CC-4ED4-8D55-DA1CB759E98A

P356

P1433

Scientific Reports

P1476

SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors

@en

P2093

Elisabeth Berber

http://www.w3.org/2001/XMLSchema#string

Eriko Michishita-Kioi

http://www.w3.org/2001/XMLSchema#string

Jonathan R Pollack

http://www.w3.org/2001/XMLSchema#string

Katrin F Chua

http://www.w3.org/2001/XMLSchema#string

Misato Aonuma

http://www.w3.org/2001/XMLSchema#string

Nilotpal Roy

http://www.w3.org/2001/XMLSchema#string

Shinji Tanaka

http://www.w3.org/2001/XMLSchema#string

Shivani Malik

http://www.w3.org/2001/XMLSchema#string

P2860

Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.

An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB

Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins

Epigenetic control of rDNA loci in response to intracellular energy status

SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span

SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation

Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription

Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues

Altered sirtuin expression is associated with node-positive breast cancer

Matrix metalloproteinase 1: role in sarcoma biology

P2888

P304

9841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP09841

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Lidia Villanova

P577

2015-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275661112

http://www.w3.org/2001/XMLSchema#string

P698

25923013

http://www.w3.org/2001/XMLSchema#string

P932

4413894

http://www.w3.org/2001/XMLSchema#string